Accumulation of p53 and Ki-67 Expression Do Not Predict Survival in Patients with Fibrillary Astrocytomas or the Response of These Tumors to Radiotherapy

Abstract

Immunohistochemical assessment of p53 accumulation and Ki-67 expression does not help in predicting the survival of patients with supratentorial fibrillary astrocytomas or in predicting whether particular patients are likely to benefit from radiotherapy.